Daily Stock Analysis, DXCM, DexCom Inc, priceseries

DexCom Inc. Daily Stock Analysis
Stock Information
Open
402.22
Close
407.35
High
415.48
Low
398.06
Previous Close
400.21
Daily Price Gain
7.14
YTD High
428.59
YTD High Date
May 18, 2020
YTD Low
182.07
YTD Low Date
Mar 17, 2020
YTD Price Change
187.97
YTD Gain
85.68%
52 Week High
428.59
52 Week High Date
May 18, 2020
52 Week Low
138.28
52 Week Low Date
Sep 10, 2019
52 Week Price Change
261.73
52 Week Gain
179.73%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Jan 10. 2017
67.04
Jan 30. 2017
78.81
13 Trading Days
17.55%
Link
LONG
Jun 12. 2017
71.68
Jun 27. 2017
75.27
11 Trading Days
5.01%
Link
LONG
Nov 2. 2017
47.72
Dec 11. 2017
58.62
26 Trading Days
22.85%
Link
LONG
Mar 20. 2018
65.59
Apr 6. 2018
70.29
12 Trading Days
7.17%
Link
LONG
May 2. 2018
74.31
Jun 7. 2018
89.89
25 Trading Days
20.97%
Link
LONG
Aug 16. 2018
128.31
Sep 14. 2018
141.98
20 Trading Days
10.66%
Link
LONG
Nov 6. 2018
132.92
Nov 14. 2018
140.00
6 Trading Days
5.32%
Link
LONG
Jan 7. 2019
129.95
Jan 24. 2019
144.39
12 Trading Days
11.11%
Link
LONG
Jun 7. 2019
125.98
Jun 25. 2019
145.33
12 Trading Days
15.36%
Link
LONG
Aug 15. 2019
158.53
Sep 4. 2019
170.96
13 Trading Days
7.84%
Link
LONG
Nov 7. 2019
194.70
Dec 9. 2019
220.95
21 Trading Days
13.48%
Link
LONG
Feb 13. 2020
252.21
Feb 26. 2020
280.91
8 Trading Days
11.38%
Link
LONG
Mar 24. 2020
236.21
Apr 7. 2020
256.82
10 Trading Days
8.73%
Link
LONG
Apr 14. 2020
280.67
Apr 28. 2020
315.58
10 Trading Days
12.44%
Link
LONG
May 1. 2020
341.52
May 20. 2020
400.91
13 Trading Days
17.39%
Link
Company Information
Stock Symbol
DXCM
Exchange
NasdaqGS
Company URL
http://www.dexcom.com
Company Phone
8582000200
CEO
Kevin Ronald Sayer
Headquarters
California
Business Address
6340 SEQUENCE DRIVE, SAN DIEGO, CA 92121
Sector
Equity
Industry Category
Health Services
Industry Group
Medical Laboratories & Research
CIK
0001093557
About

DexCom, Inc. is a medical device manufacturing company. The company is focused on the design, development and commercialization of continuous glucose monitoring systems for ambulatory use by people with diabetes and for use by healthcare providers in the hospital for the treatment of both diabetic and non-diabetic patients. Its products include Dexcom G4 PLATINUM System, Dexcom studio and Mobile apps. The company was founded by John F. Burd in May 1999 and is headquartered in San Diego, CA.

Description

DexCom, Inc., a medical device company, together with its subsidiaries, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company offers its systems for ambulatory use by people with diabetes; and for use by healthcare providers in the hospital for the treatment of patients with and without diabetes. Its products include DexCom G4 PLATINUM system for continuous use by adults with diabetes; DexCom G4 PLATINUM with Share, a remote monitoring system; and DexCom G5 Mobile, a CGM system that directly communicates to a patient's mobile and its data can be integrated with DexCom CLARITY, which is a next generation cloud-based reporting software for personalized, easy-to-understand analysis of trends to improve diabetes management. The company also offers sensor augmented insulin pumps. It has a collaboration and license agreement with Verily Life Sciences LLC to develop a series of next-generation CGM products. The company markets its products directly to endocrinologists, physicians, and diabetes educators. The company was founded in 1999 and is headquartered in San Diego, California.